We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Advanced Melanoma

Journal Scan / Research · January 13, 2021

Clinical Characteristics and Treatment Response With Checkpoint Inhibitors in Vulvovaginal Malignant Melanoma

Journal of Lower Genital Tract Disease

 

Additional Info

Journal of Lower Genital Tract Disease
Clinical Characteristics and Treatment Response With Checkpoint Inhibitors in Malignant Melanoma of the Vulva and Vagina
J Low Genit Tract Dis 2020 Nov 24;[EPub Ahead of Print], C Wohlmuth, I Wohlmuth-Wieser, S Laframboise

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading